scholarly journals Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Enric Jané-Salas ◽  
Rui Albuquerque ◽  
Aura Font-Muñoz ◽  
Beatríz González-Navarro ◽  
Albert Estrugo Devesa ◽  
...  
Keyword(s):  
Giant Cell ◽  
Successful Treatment ◽  
Case Reports ◽  
Pyogenic Granuloma ◽  
Relevant Information ◽  
Cochrane Library ◽  
Giant Cell Granuloma ◽  
National Library ◽  
Level Of Evidence ◽  
Peripheral Giant Cell Granuloma

Introduction. Pyogenic granuloma (PG) and peripheral giant-cell granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed.Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words “granuloma”, “oral”, and “implants” from the last 15 years on the databases Pubmed, National Library of Medicine’s Medline, Scielo, Scopus, and Cochrane Library.Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective.Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

scholarly journals Reactive Hyperplastic Lesions of the Gingiva: A Retrospective Study of 260 Cases

2012 ◽  
Vol 3 (2) ◽  
pp. 126-130 ◽  
Author(s):  
Sangeetha Ramu ◽  
Charlotte Rodrigues
Keyword(s):  
Retrospective Study ◽  
Giant Cell ◽  
Pyogenic Granuloma ◽  
Ossifying Fibroma ◽  
Giant Cell Granuloma ◽  
Multicenter Studies ◽  
Age And Gender ◽  
Peripheral Giant Cell Granuloma ◽  
The Mean ◽  
And Gender

ABSTRACT Objectives The purpose of the study was to analyze the frequency and distribution of gingival lesions in MR Ambedkar Dental College, Bengaluru. Materials and methods The material included the biopsies of all localized reactive hyperplastic lesions (LRHL) of the gingiva stored in the department's database (1995-2011). The lesions were analyzed according to their location and the patient's age and gender. The findings were compared with other published studies on reactive lesions. Results A total of 260 reactive lesion biopsies were accessed. focal fibrous hyperplasia (FFH) was the most common (38.5%), followed by pyogenic granuloma (PG) (34.6%), peripheral ossifying fibroma (POF) (17.7%) and peripheral giant cell granuloma (PGCG) (9.2%). The mean age of the patients was 33 years, with a range varying from 9 to 80 years. The LRHL occurred more commonly in females except focal fibrous hyperplasia, which showed male predilection. PG and POF were more common in the maxilla and FFH as well as PGCG were more common in the mandible. Conclusion This study indicates some differences in age and gender distribution as well as in location between the different lesions. The results of this study differ from those of other studies and the data presented here can be used as a guide for further multicenter studies. How to cite this article Ramu S, Rodrigues C. Reactive Hyperplastic Lesions of the Gingiva: A Retrospective Study of 260 Cases. World J Dent 2012;3(2):126-130.

scholarly journals Angiomyolipoma of the Oral Cavity: A Rare Case Report

2019 ◽  
pp. 107-110
Author(s):  
Sara Amanpour ◽  
Mohammad Reza Zarei ◽  
Javad Faryabi ◽  
Ahmad Ahrari
Keyword(s):  
Oral Cavity ◽  
Giant Cell ◽  
Case Reports ◽  
Thick Wall ◽  
Giant Cell Granuloma ◽  
First Case ◽  
Peripheral Giant Cell Granuloma ◽  
Rare Case Report ◽  
Rare Benign Tumor ◽  
Local Trauma

Angiomyolipoma (AML) is a rare, benign tumor composed of thick-wall blood vessels, smooth muscle component and mature adispose tissue. Differentiation from other benign and malignant mesenchymal lesions of oral cavity depends on recognition of these three histologic components, and immunohistochemical (IHC) techniques are also helpful. This tumor arise from perivascular epithelioid cells (PEComas) and kidneys followed by liver are the main locations of this soft tissue tumor. AMLs are rarely found in oral cavity and few case reports of oral AML have been reported in the literature. We report the first case of concurrent occurrence of AML of the tongue and peripheral giant cell granuloma of the gingiva in a 59-year-old patient. Clinically it was presented as a painless nodular mass with a smooth surface on the dorsal of the tongue. Based on histopathologic features and IHC staining the diagnosis of oral AML was done. The other lesion was a small sessile mass in interdental papillae of the lower incisors and microscopic examination showed the histologic features of a peripheral giant cell granuloma. Concurrent occurrence of PGCG which is a reactive mucosal hyperplasia and AML in our patient, could show the probable role of local trauma in the pathogenesis of these lesions.

scholarly journals Inflammatory (Reactive) Hyperplastic conditions in puberty

2020 ◽  
Vol 6 (2) ◽  
pp. 109-111
Author(s):  
Vinita Thapa ◽  
Preeti Dhawan ◽  
Nitin Khanduri ◽  
Brijesh Gupta
Keyword(s):  
Giant Cell ◽  
Pyogenic Granuloma ◽  
Ossifying Fibroma ◽  
Giant Cell Granuloma ◽  
Peripheral Ossifying Fibroma ◽  
Peripheral Giant Cell Granuloma ◽  
Localize Growth

The gingiva is often the site of localize growth that are considered to be reactive rather than neoplastic in nature.Many of these lesions are difficult to be identified clinically and can only be identified by histological examination.Many types of localized reactive lesions occurring on the gingiva includes focal fibrous hyperplasia, pyogenic granuloma, peripheral giant cell granuloma and peripheral ossifying fibroma . Clinical reports of  12 and 13 year old girls with Pyogenic Granuloma and Peripheral ossifying fibroma are presented.

scholarly journals An analysis of the prevalence of peripheral giant cell granuloma and pyogenic granuloma in relation to a dental implant

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Nieves Román-Quesada ◽  
Beatriz González-Navarro ◽  
Keila Izquierdo-Gómez ◽  
Enric Jané-Salas ◽  
Antonio Marí-Roig ◽  
...  
Keyword(s):  
Giant Cell ◽  
Dental Implants ◽  
Recurrence Rate ◽  
Pyogenic Granuloma ◽  
High Recurrence Rate ◽  
Ossifying Fibroma ◽  
Giant Cell Granuloma ◽  
Oral Implants ◽  
Time Restrictions ◽  
Peripheral Giant Cell Granuloma

Abstract Background The aim of the present investigation was to evaluate the literature recurrence of peripheral giant cell granuloma and pyogenic granuloma associated with dental implants. It’s important to know the characteristics present in these lesions and possible effects on the prognosis of dental implants. Methods An electronic search without time restrictions was done in the databases: PubMed/Medline. With the keywords "Granuloma" OR "Granuloma, Giant Cell" OR "peripheral giant cell" OR "Granuloma, Pyogenic” AND "Dental implants" OR "Oral implants”. Results After applying the inclusion and exclusion criteria, a total of 20 articles were included, which reported 32 lesions (10 pyogenic granulomas, 21 peripheral giant cell granulomas and one peripheral giant cell granuloma combined with peripheral ossifying fibroma, all associated with implants). According to our review, these lesions are more frequent in males and in the posterior region of the mandible. Both excision and curettage of the lesion, compared to only excision, presented similar recurrences (40%). Explantation of the implant was performed in 41% of cases without additional recurrences. The results are not statistically significant when comparing one lesion to the other in terms of explantation (p = 0.97), recurrence (p = 0.57) or bone loss (p = 0.67). Conclusions The main therapeutic approach is tissue excision. The lesions show a high recurrence rate (34.4%), which often requires explantation of the associated implant. This recurrence rate is not affected by curettage after excision.

scholarly journals Retrospective Clinicopathological Analysis of 65 Peri-Implant Lesions

Medicina ◽  
2021 ◽  
Vol 57 (10) ◽  
pp. 1069
Author(s):  
Amir Shuster ◽  
Gal Frenkel ◽  
Shlomi Kleinman ◽  
Oren Peleg ◽  
Clariel Ianculovici ◽  
...  
Keyword(s):  
Giant Cell ◽  
Recurrence Rate ◽  
Pyogenic Granuloma ◽  
Common Finding ◽  
Histopathological Analysis ◽  
Giant Cell Granuloma ◽  
Epithelial Hyperplasia ◽  
Clinicopathological Analysis ◽  
Peripheral Giant Cell Granuloma

Background and Objectives: Peri-implantitis is a common finding among patients with dental implants. There is no consensus regarding the treatment of this disease, but in many cases, surgical treatment is common practice. A histopathological analysis is not an integral part of suggested protocols. The present study investigated the clinical and histopathological parameters of lesions mimicking peri-implantitis and correlated them with the outcome and follow-up data. Materials and Methods: The study included 65 consecutive biopsies taken from peri-implantitis patients between 2008–2019. Results: The three common diagnoses were fibro-epithelial hyperplasia 20 (30.7%), pyogenic granuloma 16 (24.6%), and peripheral giant cell granuloma 15 (23%). There were 18 cases of recurrent lesions in the study group (27.7%). The recurrence rate was the highest in peripheral giant cell granuloma (8, 12.3%), versus 6% in pyogenic granuloma and fibro-epithelial hyperplasia. These differences in the recurrence rate were statistically significant (p = 0.014). Conclusions: This study emphasizes the necessity of submitting tissue of peri-implantitis cases for histopathological analysis since the more locally aggressive lesions (peripheral giant cell granuloma and pyogenic granuloma), which comprise nearly half of the cases in this study, do not differ in clinical or radiographic characteristics from other peri-implant lesions.

Peripheral giant cell granuloma: A case report and review

2017 ◽  
Vol 4 (1) ◽  
pp. 1-3
Author(s):  
Tejavathi Nagaraj ◽  
Lakshmi Balraj ◽  
Pooja Sinha ◽  
Sreelakshmi Narayanan
Keyword(s):  
Case Report ◽  
Giant Cell ◽  
Giant Cell Granuloma ◽  
Peripheral Giant Cell Granuloma

scholarly journals Massive peripheral giant cell granuloma associated with pregnancy

2016 ◽  
Author(s):  
Vikas Jain
Keyword(s):  
Oral Cavity ◽  
Giant Cell ◽  
Ovarian Hormones ◽  
Contributory Factor ◽  
Hormonal Changes ◽  
Giant Cell Granuloma ◽  
Young Females ◽  
Peripheral Giant Cell Granuloma ◽  
Nodular Lesions

Peripheral giant cell granuloma (PGCG) is a relatively Common reactive exophytic lesion of the oral cavity. The influence of hormones has been suggested as contributory factor in PGCG development and predominance of these lesions in young females as well as some previously reported pregnancy related cases support this belief. It has been observed that majority of lesions present in the 4th decade of life, when hormonal changes are more pronounced. Cailluette and Mattar in their study found that peripheral giant cell granuloma are under the influence of the ovarian hormones. However Chambers and Spector suggested peripheral giant cell granuloma to be enhanced by pregnancy rather than being pregnancy dependent. The responsiveness of gingiva to these hormones along with the immunosuppressive actions of the hormones contributes to the growth of the lesion. Clinically, PGCGs may present as polypoid or nodular lesions, predominantly bluish red with a smooth shiny or mamillated surface.This poster will review the literature available on the association of Massive Peripheral Giant Cell Granuloma With Pregnancy with focus on possible causes of PGCG during pregnancy.

Sign in / Sign up

Export Citation Format

Share Document